Table 1 The median concentration of PFAS (ng/mL) in the serum of the participants.
N (weighted %) | PFOA | PFNA | PFDA | PFUnDA | PFHxS | PFOS | |
|---|---|---|---|---|---|---|---|
Overall | |||||||
No Diseases | 789 (29.6) | 1.37 | 0.5 | 0.2 | 0.1 | 0.9 | 3.9 |
Hypertension | 224 (8.4) | 1.57 | 0.5 | 0.2 | 0.1 | 1.2 | 5.6 |
Hyperlipidemia | 909 (34.1) | 1.57 | 0.5 | 0.2 | 0.1 | 1.3 | 5 |
Comorbidity | 743 (27.9) | 1.77 | 0.7 | 0.2 | 0.1 | 1.5 | 7.1 |
P | < 0.05a | < 0.05a | < 0.05b | < 0.05b | < 0.05a | < 0.05c | |
Gender | |||||||
Male | |||||||
No Diseases | 318 (24.5) | 1.67 | 0.5 | 0.2 | 0.1 | 1.6 | 6 |
P (F) | < 0.05 | < 0.05 | < 0.05 | 0.40 | < 0.05 | < 0.05 | |
Hypertension | 107 (8.2) | 1.67 | 0.5 | 0.2 | 0.1 | 1.6 | 7 |
P (F) | < 0.05 | 0.11 | 0.54 | 0.28 | < 0.05 | < 0.05 | |
Hyperlipidemia | 508 (39.2) | 1.77 | 0.6 | 0.2 | 0.1 | 1.6 | 6.4 |
P (F) | < 0.05 | < 0.05 | < 0.05 | 0.63 | < 0.05 | < 0.05 | |
Comorbidity | 364 (28.1) | 1.97 | 0.7 | 0.2 | 0.1 | 1.7 | 8.6 |
P (F) | < 0.05 | 0.64 | 0.53 | 0.80 | < 0.05 | < 0.05 | |
Female | |||||||
No Diseases | 471 (34.4) | 1.07 | 0.4 | 0.2 | 0.1 | 0.6 | 2.8 |
Hypertension | 117 (8.6) | 1.47 | 0.5 | 0.2 | 0.07 | 1 | 4.7 |
Hyperlipidemia | 401 (29.3) | 1.27 | 0.5 | 0.2 | 0.1 | 0.8 | 3.5 |
Comorbidity | 379 (27.7) | 1.57 | 0.7 | 0.2 | 0.1 | 1.2 | 5.7 |
Age | |||||||
20–59 | |||||||
No Diseases | 709 (40.1) | 1.27 | 0.4 | 0.2 | 0.1 | 0.8 | 3.6 |
P (OA) | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | |
Hypertension | 109 (6.2) | 1.27 | 0.5 | 0.2 | 0.1 | 1.1 | 4.1 |
P (OA) | < 0.05 | < 0.05 | 0.10 | 0.97 | < 0.05 | < 0.05 | |
Hyperlipidemia | 683 (38.6) | 1.37 | 0.5 | 0.2 | 0.1 | 1.2 | 4.4 |
P (OA) | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | |
Comorbidity | 267 (15.1) | 1.47 | 0.6 | 0.2 | 0.1 | 1.1 | 5.2 |
P (OA) | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | < 0.05 | |
60+ | |||||||
No Diseases | 80 (8.9) | 1.87 | 0.8 | 0.2 | 0.1 | 1.4 | 6.35 |
Hypertension | 115 (12.8) | 1.97 | 0.6 | 0.2 | 0.1 | 1.5 | 7.6 |
Hyperlipidemia | 226 (25.2) | 1.97 | 0.7 | 0.2 | 0.1 | 1.7 | 8.1 |
Comorbidity | 476 (53.1) | 1.935 | 0.7 | 0.2 | 0.1 | 1.65 | 8.45 |